Evaluation of Chromatographic Parameters Influencing GLP-1 Peptide Impurity Profiling
Technical Reference Summary
Covered Models & Document Scope
Application note covering reversed-phase LC method development for GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) and their related impurities using the Agilent Altura Peptide Plus column (part number 227215-903) with the Agilent 1260 Infinity III Prime Bio LC system and Agilent InfinityLab Pro iQ Plus; no instrument model variants or ordering codes are defined.
Technical Data
| Parameter | Value | Condition |
|---|---|---|
| Analytical column | Agilent Altura Peptide Plus p.2 ↗ | part number 227215-903 |
| Column particle size | 2.7 µm p.9 ↗ | Altura Peptide Plus |
| LC system | Agilent 1260 Infinity III Prime Bio LC p.1 ↗ | |
| Detector | Agilent InfinityLab Pro iQ Plus p.1 ↗ | |
| Ion source | Agilent Jet Stream ESI source p.3 ↗ | |
| Sheath gas flow | 12 L/min p.3 ↗ | |
| Gas temperature | 270 °C p.3 ↗ | |
| Injection volume | 1.0 µL p.3 ↗ | |
| DAD flow cell | Agilent InfinityLab Bio-inert Max-Light p.3 ↗ | |
| Mobile-phase additive (TFA) concentration | 0.05 % p.5 ↗ | best overall chromatographic performance |
| Column compartment temperature | 60 °C p.10 ↗ | semaglutide and liraglutide |
| Sample loading amount | 1.2 µg p.9 ↗ | Altura Peptide Plus, 2.7 µm |
| Mobile-phase additive (FA) concentration | 0.4 % p.6 ↗ | tirzepatide |
Operating Limits
- Column compartment temperature evaluated: 60–70 °C p.10 ↗
- TFA concentration evaluated: 0.05–1% p.5 ↗
- FA concentration evaluated: 0.4% p.6 ↗